BAYCOX DIN 02355353
Status: Marketed
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | TOLTRAZURIL 50 MG |
|---|
| Dosage form | Suspension |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 21-Oct-2010 |
|---|
| Current status date | 09-Dec-2021 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TOLTRAZURIL
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02487179 | FORCERIS | CEVA ANIMAL HEALTH INC | Suspension | TOLTRAZURIL 30 MG; IRON (GLEPTOFERRON) 133.4 MG | Marketed |
| 02541017 | ZOLTROX | ZOETIS CANADA INC | Suspension | TOLTRAZURIL 50 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 24551 | 2020-11-03 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 16513 | 2015-01-12 | Supplement to a New Drug Submission (SNDS) | NEW SPECIES: CATTLE |
| 15026 | 2013-12-12 | Supplement to a New Drug Submission (SNDS) | NEW SPECIES; LAMBS |
| 11671 | 2010-08-20 | New Drug Submission (NDS) | |
Request a quote for BAYCOX
How to read a Canadian DIN record